Suscribirse

One-stage bilateral total hip arthroplasty versus unilateral total hip arthroplasty: A retrospective case-matched study - 25/04/20

Doi : 10.1016/j.otsr.2020.02.003 
Grégoire Micicoi a, Régis Bernard de Dompsure a, Lolita Micicoi a, Laurie Tran b, Michel Carles c, Pascal Boileau a, Christophe Trojani a,
a Service de chirurgie orthopédique et chirurgie du sport, Institut universitaire locomoteur et du sport (IULS), hôpital Pasteur 2, 30, voie Romaine, 06000 Nice, France 
b Service d’anesthésie-réanimation, institut Arnault Tzanck, 171, rue du Commandant Gaston Cahuzac, 06700 Saint-Laurent-du-Var, France 
c Service d’anesthésie-réanimation, CHU de la Guadeloupe, route Chauvel, 97110 Pointe-à-Pitre, France 

Corresponding author.

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Abstract

Background

One-stage bilateral hip replacement has the advantage of involving a single anesthesia, single hospital admission and single rehabilitation program. The theoretic drawback is increased surgical risk. Few French series have been reported, and none with comparison versus unilateral arthroplasty. We therefore conducted a comparative case-control study between 1-stage bilateral (1B-THA) and unilateral total hip arthroplasty (U-THA), assessing (1) morbidity/mortality, (2) survival, and (3) functional scores and forgotten hip rates.

Hypothesis

In a selected ASA 1 or 2 population, 1B-THA shows complications rates and implant survival comparable to U-THA.

Material and method

Between 2004 and 2018, 327 patients were included: 109 with 1B-THA, 218 with U-THA. One 1B-THA patient was matched to 2 U-THA patients on age, gender, diagnosis, ASA score 1 or 2, and anterior or posterior approach. Minimum follow-up was 12 months. Complications were collected for all patients in both groups. Early (≤90 days) or late (>90 days) morbidity/mortality and implant survival were recorded for both groups. Secondary endpoints concerned blood-sparing strategy and blood loss, functional scores, and patient satisfaction.

Results

Mortality was zero in both groups. There was no significant difference in complications rates (1B-THA 38.5%, U-THA 40.8%) (p=0.69), whether early (8.3% [9/109] and 7.8% [17/218] respectively [p=0.89]) or late (30.3% [33/109] and 33.0% [72/218] respectively [p=0.61]). Limb-length discrepancy was significantly less frequent in 1B-THA (5.5% [6/109] versus 13.3% [29/218] [p=0.03]). Forgotten hip rate was significantly more frequent in 1B-THA (86% [94/109] versus 70% [152/218] [p=0.01]). Five-year Kaplan-Meier implant survival was 97.2% (95% CI [91.9–99.1]) in 1B-THA and 96.6% (95% CI [93.0–98.4]) in U-THA (p=0.08).

Discussion

One-stage bilateral total hip arthroplasty gave acceptable results in disabling bilateral osteoarthritis of the hip with low surgical risk in selected patients (ASA 1 or 2). Mortality, complications and implant survival were unaffected, but the 1-stage bilateral procedure allowed better control of limb-length and provided a higher rate of forgotten hip.

Level of evidence

III, matched case-control study.

El texto completo de este artículo está disponible en PDF.

Keywords : Hip osteoarthritis, Bilateral total hip arthroplasty, 1-stage procedure, Postoperative morbidity, Unilateral, Complications, Outcome


Esquema


© 2020  Publicado por Elsevier Masson SAS.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 106 - N° 3

P. 577-581 - mai 2020 Regresar al número
Artículo precedente Artículo precedente
  • Femoroacetabular impingement treatment using the arthroscopic extracapsular outside-in approach: Does capsular suture affect functional outcome?
  • Mathieu Thaunat, Saliou Sarr, Thanos Georgeokostas, Abdul Azeem, Colin G Murphy, Samih Kacem, Gilles Clowez, Timothy Roberts
| Artículo siguiente Artículo siguiente
  • Anterior approach without traction table: A means of saving time and money in hemiarthroplasty for femoral neck fracture? A case-matched study with and without traction table
  • Elliott Kierszbaum, David Biau, Aymane Moslemi, Jules Descamps, Philippe Anract, Alexandre Hardy

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2024 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.